DLK Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Sell
19,109
-1,261
-6% -$432K 2.54% 12
2026
Q1
$7.17M Sell
20,370
-612
-3% -$218K 2.83% 12
2025
Q4
$6.87M Buy
20,982
+123
+0.6% +$39K 2.56% 13
2025
Q3
$5.89M Buy
20,859
+37
+0.2% +$10.7K 2.22% 19
2025
Q2
$5.81M Buy
20,822
+331
+2% +$93.8K 2.2% 17
2025
Q1
$6.38M Buy
20,491
+1,387
+7% +$410K 2.67% 13
2024
Q4
$4.98M Sell
19,104
-120
-0.6% -$35.6K 2.08% 20
2024
Q3
$6.19M Buy
19,224
+115
+0.6% +$37.6K 2.37% 16
2024
Q2
$5.97M Buy
19,109
+5
+0% +$1.47K 2.47% 13
2024
Q1
$5.43M Buy
19,104
+260
+1% +$76.1K 2.31% 17
2023
Q4
$5.43M Buy
+18,844
New +$5.13M 2.47% 16

Other funds holding AMGN

DLK Investment Management's AMGN Position: Q2 2026 in Review

DLK Investment Management reduced its Amgen (AMGN) stake by 6.2% in Q2 2026, selling an estimated $432K and leaving 19,109 shares worth $5.97M. The position accounts for 2.54% of the portfolio, ranked #12.

DLK Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.17M in Q1 2026. 889 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DLK Investment Management held 19,109 shares of Amgen worth $5.97M as of Q2 2026.
  • DLK Investment Management sold 1,261 Amgen shares in Q2 2026, an estimated $432K.
  • Amgen made up 2.54% of DLK Investment Management's portfolio in Q2 2026, its #12 holding.
  • DLK Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • DLK Investment Management's Amgen position peaked at $7.17M in Q1 2026.
  • 889 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.